The present invention relates to compositions and methods of treating and
diagnosing disorders characterized the by the presence of antigens
associated with inflammatory diseases and/or cancer, and nucleotide
sequences, including expressed sequence tags (ESTs), oligonucleotide
probes, polypeptides, vectors and host cells expressing such antigens
PRO301, PRO362 or PRO245.